Secretory phospholipase A2 elicits proinflammatory changes and upregulates the surface expression of Fas ligand in monocytic cells: Potential relevance for atherogenesis

Circulation Research

Volumn 90, Issue 1, 2002, Pages 38-45

  Hernández, Marita ^a   Fuentes, Lucía ^a   Fernández Avilés, Francisco Javier ^a   Sánchez Crespo, Mariano ^a   Nieto, María Luisa ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Apoptosis; Atherosclerosis; Chemokines; Inflammation; Lipid mediators

Indexed keywords

ACUTE PHASE PROTEIN; ARACHIDONIC ACID; CYCLOOXYGENASE 2; FAS ANTIGEN; FAS LIGAND; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHOLIPASE A2; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ARACHIDONIC ACID METABOLISM; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME INDUCTION; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ARTERIOSCLEROSIS; CELL LINE; CHEMOKINE CCL2; CYCLOOXYGENASE 2; ENZYME ACTIVATION; FAS LIGAND PROTEIN; FLAVONOIDS; HUMANS; ISOENZYMES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; JURKAT CELLS; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; MONOCYTES; NF-KAPPA B; PHOSPHOLIPASES A; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RECEPTORS, CELL SURFACE; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 0037059514     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/hh0102.102978     Document Type: Article

References (45)

1. 2 mediates inflammatory hyperaemia
2. 2
3. 2 in human atherosclerotic plaques
4. 2 isoforms in human normal and atherosclerotic arterial wall
5. 2 in normal and atherosclerotic arteries: Activity of the isolated enzyme on low-density lipoproteins
6. 2 and decorin in human atherosclerotic lesions
7. The proteoglycan decorin links low density lipoproteins with collagen type I
8. Decorin links low-density lipoproteins (LDL) to collagen: A novel mechanism for retention of LDL in the atherosclerotic plaque
9. Lipoprotein lipase (LPL) strongly links native and oxidized low density lipoprotein particles to decorin-coated collagen: Roles for both dimeric and monomeric forms of LPL
10. 2
11. 2 predict coronary events in patients with coronary artery disease
12. 2 in Swiss 3T3 cells via specific binding site
13. 2
14. 2 with the glycosylphosphatidylinositol-anchored heparan sulfate proteoglycan in the cyclooxygenase-2-mediated delayed prostanoid-biosynthetic pathway
15. 2 in the human astrocytoma cell line 1321N1
16. 2+ mobilization in the human astrocytoma cell line 1321N1 by a mechanism independent of its catalytic activity
17. 2 induce β-glucuronidase release from human lung macrophages
18. 2 in human monocyte-derived macrophages
19. 2 from plasma of patients with septic shock is associated with high-density lipoproteins and C3 anaphylatoxin: Some implications for its functional role
20. 2 receptors from various mammals
21. 2: Cloning, identification of a secreted soluble form, expression, and chromosomal localization
22. Stimulation of FcγR receptors induces monocyte chemoattractant protein-1 (MCP-I) in the human monocytic cell line THP-1 by a mechanism involving IκB-α degradation and formation of p50/p65 NF-κB/Rel complexes
23. Expression and purification of glutathione-S-transferase fusion proteins
24. Regulation of Raf-I kinase by TNF via its second messenger ceramide and cross-talk with mitogenic signalling
25. 2 and transactivation of cyclooxygenase-2
26. 2 is phosphorylated and activated by MAP kinase
27. 2 in murine bone marrow-derived mast cells
28. Cytokine induction of monocyte chemoattractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-κB and AP-1
29. CrmA-inhibitable cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein during Fas- and tumor necrosis factor-induced apoptosis
30. 2 but not the group IB, IIA, and V enzymes efficiently release arachidonic acid from adherent mammalian cells
31. 2 in transgenic mice results in epidermal hyperplasia in the absence of inflammatory infiltrate
32. 2 upregulates cyclooxygenase-2 and amplifies cytokine-mediated prostaglandin production in human rheumatoid synoviocytes
33. Regulation of mesangial cell cyclooxygenase synthesis by cytokines and glucocorticoids
34. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines
35. Transcriptional roles of nuclear factor κB and nuclear factor-interleukin-6 in the tumor necrosis factor-α dependent induction of cyclooxygenase-2 in MC3T3-E1 cells
36. Human cyclooxygenase-2 cDNA
37. Structure and expression of TIS21, a primary response gene induced by growth factors and tumor promoters
38. Human monocytic cells contain high levels of intracellular Fas ligand: Rapid release following intracellular activation
39. Phagocytosis triggers macrophage release of Fas ligand and induces apoptosis of bystander leukocytes
40. Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS)
41. Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes
42. 2 as an index of disease activity in rheumatoid arthritis: Prospective double blind study of 212 patients
43. Tumor necrosis factor-α regulation of the FAS-mediated apoptosis-signaling pathway in synovial cells
44. Vascular endothelial cells and smooth muscle cells differ in expression of Fas and Fas ligand and in sensitivity to Fas ligand-induced cell death: Implications for vascular disease and therapy
45. Sensitivity to Fas-mediated apoptosis is determined below receptor level in human vascular smooth muscle cells